Category Archives: Patents

MSF approaches Delhi High Court to challenge unmerited patent grant for pneumonia vaccine

New Delhi, 13 October 2017 – Médecins Sans Frontières/Doctors Without Borders India has filed a petition before the High Court of Delhi to overturn the patent granted on the pneumococcal conjugate vaccine (PCV) to the US pharmaceutical corporation Pfizer. Earlier … Continue reading

Posted in Indian Patent Law, Indian Patent Office, Patent, Patent examination system, Patent Opposition, Uncategorized | Tagged , , | Leave a comment

Letter: Over 30 civil society organisations urge EU to abolish supplementary protection certificates mechanism

Source: MSF Access Campaign In an open letter and open submission, thirty-three civil society organisations have called on the European Commission to abolish the supplementary protection certificates (SPC) mechanism and to stop encouraging the inclusion of SPCs – or similar mechanisms, such … Continue reading

Posted in Patent Term Extension, Uncategorized | Leave a comment

NGOs call for supplementary protection certificates to be abolished

By Carmen Paun 9/11/17, 1:43 PM CET A group of 33 civil society organizations led by Doctors Without Borders today asked the European Commission to abolish supplementary protection certificates (SPCs), which they claim lead to unaffordable medicines prices that stay in place for … Continue reading

Posted in Patent Term Extension, Uncategorized | Leave a comment

Pfizer patent for pneumonia drug could have a deadly impact on public health

India carries the world’s highest burden of pneumonia and accounts for nearly 20% of global infant pneumonia deaths Opinion piece: Leena Menghaney, The Hindustan Times India’s Patent Office has dealt a major setback to hopes for improved access to an … Continue reading

Posted in Indian Patent Law, Indian Patent Office, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Dangerous pneumonia on the loose, but affordable vaccine to get tough to procure; uproar sparked off; reason will SHOCK you

Source: The Financial Express Access to affordable pneumococcal conjugate vaccine (PCV) will become tougher after the Indian patent office granted a patent to US pharma major Pfizer for its PCV13 product, marketed as Prevnar13. Access to affordable pneumococcal conjugate vaccine … Continue reading

Posted in Indian Patent Office, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

India grants patent to Pfizer’s pneumonia vaccine despite opposition

Source: Money Control Pfizer application for patent was met with opposition from Indian vaccine maker Panacea Biotec and Medicines Sans Frontieres (MSF), a Paris-based international humanitarian-aid non-governmental organization on grounds that Pfizer is seek patent for mere addition of serotypes … Continue reading

Posted in Indian Patent Law, Patent Opposition, Patents, Uncategorized, Vaccines | Leave a comment

Amid opposition, India gives Pfizer the patent to exclusively sell vital pneumonia vaccine

Various groups believe the decision will make the shot less accessible to the poor. Source: Scroll India has granted Mumbai-based pharmaceutical company Pfizer Inc a patent for its pneumonia vaccine Prevenar 13, amid opposition from groups that say the decision … Continue reading

Posted in Indian Patent Office, Patent Opposition, Uncategorized, Vaccines | Leave a comment